Skip to content

The Short-term Impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on Respiratory Function in Patients With Lung Cancer

The Short-term Impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on Respiratory Function in Patients With Lung Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06172959
Enrollment
1
Registered
2023-12-15
Start date
2024-02-21
Completion date
2024-06-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The purpose of this study is to examine the short-term impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on respiratory function in patients with lung cancer. As a secondary outcome, this research will evaluate the effect of the music intervention on respiratory quality of life.

Interventions

BEHAVIORALVocal Intonation Therapy (VIT)

Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Vocal Intonation Therapy is a music therapy technique consisting of breathing and vocal exercises to target respiratory function and vocal quality.

BEHAVIORALTherapeutic Singing (TS)

Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Therapeutic Singing is a music therapy technique used to work on the rehabilitation of vocal and respiratory function.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Participants will include three patients diagnosed with lung cancer, stages I-III, who have undergone a thoracentesis or thoracotomy in the last 12 months. Thoracic surgical procedures include pulmonary lobectomy or cancer-related surgical procedure (e.g., pneumonectomy). This diagnosis must be made by the patient's oncologist and medical team. * The age range will be 40 to 80 years old. Both female and male participants from any race and ethnicity will be included in the study. * The study will include English and Spanish speakers only. * Patients must have less than five years of voice training experience (e.g., choir, private voice lessons).

Exclusion criteria

* Patients in respiratory failure * Individuals with severe neurological and hearing impairments. * Patients with diagnosed dysphonia and individuals who have undergone a laryngectomy * Participants that do not have access to an electronic device, either an iPad, tablet, or laptop, as well as reliable internet access. They will also need to have adequate knowledge of technology or participate with a caregiver who knows how to navigate Zoom. * Participants who do not have access to a quiet space. Headphones are optional for this study. * Prisoners * Persons under the age of 40 or over the age of 80.

Design outcomes

Primary

MeasureTime frameDescription
Change in Maximum Phonation Time (MPT) in secondsBaseline, up to 30-minutes (Post-Intervention)Maximum Phonation Time (MPT) measures the number of seconds a participant can sustain a phonated sound.
Respiratory RateUp to 30-minutesMeasured by the number of breaths per minute
Change in Dyspnea measured by Dyspnea-12 QuestionnaireBaseline, up to 1 monthScores range from 0 to 3. Higher scores suggest more severity in shortness of breath
Change in Dyspnea measured by Modified Borg ScaleBaseline, up to 30-minutes (Post-Intervention)Scores change from 0 to 10. Higher scores suggest more severity in shortness of breath
Change in Respiratory Quality of Life measured by St.Georges Respiratory QuestionnaireBaseline, up to 1 monthA composite score will be obtained, ranging from 0 to 100. Higher scores indicate worst respiratory quality of life
Change in Dyspnea measured by Cancer Dyspnea ScaleBaseline, up to 1 monthScores range from 1 (Not at all) to 5 (Very much). Higher scores suggest more severity of dyspnea

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026